ADAP - Adaptimmune GAAP EPS of -$0.03 beats by $0.04 revenue of $5.7M misses by $11.37M May, 15 2024 07:45 AM Adaptimmune Therapeutics plc 2024-05-15 07:45:41 ET More on Adaptimmune Adaptimmune: Huge Opportunity Amid Their Setback With Genentech Adaptimmune Therapeutics gets $125M in financing from Hercules Capital Adaptimmune falls as Roche strategic collaboration ends Seeking Alpha’s Quant Rating on Adaptimmune For further details see: Adaptimmune GAAP EPS of -$0.03 beats by $0.04, revenue of $5.7M misses by $11.37M